Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1777800 | 0.82 | SMN1; SMN2 (0.39) | GAAALDH1A1LMNASMN1; SMN2TSHR | |
| SCHEMBL7262 | 0.79 | ALDH1A1 (0.62) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL9823358 | 0.79 | ALDH1A1 (0.62) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL1331989 | 0.79 | ALDH1A1 (0.62) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL10840657 | 0.78 | — | — | |
| SCHEMBL7768993 | 0.77 | ALOX15 (0.46) | GAAALOX15MGAMSIMGAM2 | |
| Hydrazine SCHEMBL3999673 | 0.76 | ALOX15 (0.55) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL9751764 | 0.76 | ALDH1A1 (0.59) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL30076441 | 0.76 | ALDH1A1 (0.59) | GAAALOX15MGAMSIMGAM2 | |
| Ammonia Solution, Strong SCHEMBL12803984 | 0.76 | ALDH1A1 (0.59) | GAAALOX15MGAMSIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108746656-B | Pre-alloyed powder for diamond products and preparation method thereof | 威海职业学院 | 2021-11-26 | — | — | CN | claimed |
| US-20260027113-A1 | PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE | SOLEY THERAPEUTICS INC (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4680608-A1 | 2,6-DIHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE DERIVATIVES AS ANTI-MALARIAL AGENTS | MMV Medicines for Malaria Venture (CH) | 2026-01-21 | — | — | EP | disclosed |
| US-12465603-B2 | Phthalazinone based modulators for the treatment of disease | SOLEY THERAPEUTICS, INC. (US) | 2025-11-11 | — | — | US | disclosed |
| EP-4619387-A1 | PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE | Soley Therapeutics, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| WO-2025077721-A1 | MYT1 INHIBITOR BASED ON FUSED THIAZOLE OR PYRIDINE RING | PHARMAENGINE, INC. (CN) | 2025-04-17 | — | — | WO | disclosed |
| CN-114787155-B | Pharmaceutical compounds | 辉瑞公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20240374589-A1 | PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE | SOLEY THERAPEUTICS, INC. | 2024-11-14 | — | — | US | disclosed |
| WO-2024199260-A1 | PYRAZOL-5-ETHER COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 南通泰禾化工股份有限公司 | 2024-10-03 | — | — | WO | disclosed |
| CN-118702628-A | Pyrazole-5-ether compound as well as preparation method and application thereof | 南通泰禾化工股份有限公司 | 2024-09-27 | — | — | CN | disclosed |
| EP-0326873-A2 | Teicoplanin hydrazides | GRUPPO LEPETIT S.p.A. (IT) | 1989-08-09 | — | — | EP | disclosed |
| US-4365062-A | BACTERICIDAL ANTIBIOTICS | RHONE-POULENC INDUSTRIES (FR) | 1982-12-21 | — | — | US | disclosed |
| US-4307230-A | ANTIBIOTICS | RHONE-POULENC INDUSTRIES (FR) | 1981-12-22 | — | — | US | disclosed |
| US-4307233-A | ANTIBACTERIAL AGENTS | RHONE-POULENC INDUSTRIES (FR) | 1981-12-22 | — | — | US | disclosed |
| US-4307116-A | BACTERICIDES | RHONE-POULENC INDUSTRIES (FR) | 1981-12-22 | — | — | US | disclosed |
| US-4195087-A | BACTERICIDES, FEED ADDITIVES | ABIC, LTD. (IL) | 1980-03-25 | — | — | US | disclosed |
| US-4075222-A | VETERINARY MEDICINE, BACTERICIDES, FUNGICIDES, ANTIPROTOZOAN | ELI LILLY AND COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-4001230-A | ANTIBACTERIAL, ANTIPROTAZOAL | ELI LILLY AND COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
| US-3980794-A | Method for promoting growth of poultry with 3-(5-nitro-2-imidazolyl)pyrazoles | ELI LILLY AND COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
| US-3947467-A | ANTIBACTERIAL, ANTIPROTOZOAL, ANTIFUNGAL | ELI LILLY AND COMPANY (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12465603-B2 | Phthalazinone based modulators for the treatment of disease | MKI67, BCL2, CCAR2 | GAA 432/4885ALOX15 1253/4885MGAM 4213/4885 |
| US-20260027113-A1 | PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE | NCOR1, NOP56, NCOR2 | GAA 3714/4885ALOX15 2235/4885MGAM 4847/4885 |
| US-20240374589-A1 | PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE | MKI67, HDAC6, BCL2 | GAA 350/4885ALOX15 1407/4885MGAM 4156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.